A PHASE III, MULTICENTRE, INTERNATIONAL, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP, PLACEBO AND ACTIVE COMPARATORCONTROLLED CLINICAL TRIAL TO EVALUATE THE ANALGESIC EFFICACY AND SAFETY OF IBUPROFEN ARGININE/TRAMADOL 400/37.5 MG COMPARED WITH IBUPROFEN ARGININE 400 MG ALONE, TRAMADOL 50 MG ALONE AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PAIN AFTER NON-ONCOLOGICAL ABDOMINAL HYSTERECTOMY

Trial Profile

A PHASE III, MULTICENTRE, INTERNATIONAL, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP, PLACEBO AND ACTIVE COMPARATORCONTROLLED CLINICAL TRIAL TO EVALUATE THE ANALGESIC EFFICACY AND SAFETY OF IBUPROFEN ARGININE/TRAMADOL 400/37.5 MG COMPARED WITH IBUPROFEN ARGININE 400 MG ALONE, TRAMADOL 50 MG ALONE AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PAIN AFTER NON-ONCOLOGICAL ABDOMINAL HYSTERECTOMY

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs Ibuprofen arginine/tramadol (Primary) ; Ibuprofen arginine; Tramadol
  • Indications Postoperative pain
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms IOTRA
  • Sponsors Farmalider
  • Most Recent Events

    • 14 May 2016 Status changed from recruiting to completed.
    • 07 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top